Subscribe
Machinery & Materials
Markets
Logistics & Cold Chain
Newsletters
GlaxoSmithKline
More from GlaxoSmithKline
Pharmaceutical
23andMe and GSK Are Using DNA to Develop New Drugs
A partnership between the two companies has yielded six potential new drugs, but using customers’ genetic information to do so raises ethical questions.
Pharmaceutical
Brexit Contingency Plans for Pharma Industry
The EU currently supplies two-thirds of the medicines in the UK. How will Brexit affect pharmaceutical investments and manufacturing?
Pharmaceutical
New Vaccine Fights Latent TB Infections
GlaxoSmithKline has developed a tuberculosis vaccine that could prevent the development of the bacterial disease in half of the recipients.
Home
Dow Packaging's 2018 Awards for Packaging Innovation—Gold and Silver
The following are the 2018 Gold and Silver award winners.
Pharmaceutical
GSK Teams Up With 23andMe to Develop Drugs
GlaxoSmithKline has signed an agreement with home DNA test company 23andMe to collaborate on drug development.
Medical device/Packaging
GSK Recalls 600,000 Ventolin Inhalers
A manufacturing glitch at GSK’s North Carolina facility caused Ventolin inhalers to be made with a defective delivery system.
Regulatory
Get to Know Trump’s FDA Pick
President Trump’s nominee for FDA commissioner, Scott Gottlieb, could help speed up regulatory approval of drugs.
Pharmaceutical
NICE Endorses GSK’s Asthma Biologic
GlaxoSmithKline’s biologic for severe refractory eosinophilic asthma receives approval from cost regulators.
Nutraceuticals/functional
GSK Label Mistakes Athlete’s Foot with Jock Itch
Labeling issues stating “use for the cure of most jock itch" rather than "use for the cure of most athlete's foot" leads to massive recall.
